FDA applicant
Qingdao Hightop Biotech Co., Ltd.
FDA records 3 decisions for Qingdao Hightop Biotech Co., Ltd. (Qingdao, CN) from 2019 to 2024: 3 510(k) clearances. Most are in product codes NFT (Test, Amphetamine, Over The Counter) and NGL (Test, Opiates, Over The Counter). Since 2016 its 510(k)s took a median of 40 days from receipt to decision, against 50 for FDA’s reviews in the same codes and years. Its devices cite 3 predicates, 0 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Qingdao Hightop Biotech Co., Ltd.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2019.
Planning a device like Qingdao Hightop Biotech Co., Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report